Immuneering (IMRX) Goodwill (2021 - 2024)
Immuneering has reported Goodwill over the past 4 years, most recently at $6.7 million for Q3 2024.
- Quarterly results put Goodwill at $6.7 million for Q3 2024, changed 0.0% from a year ago — trailing twelve months through Sep 2024 was $6.7 million (changed 0.0% YoY), and the annual figure for FY2023 was $6.7 million, changed 0.0%.
- Goodwill for Q3 2024 was $6.7 million at Immuneering, roughly flat from $6.7 million in the prior quarter.
- Over the last five years, Goodwill for IMRX hit a ceiling of $6.7 million in Q4 2021 and a floor of $6.7 million in Q1 2022.
- Median Goodwill over the past 4 years was $6.7 million (2022), compared with a mean of $6.7 million.
- Biggest five-year swings in Goodwill: dropped 0.17% in 2022 and later changed 0.0% in 2023.
- Immuneering's Goodwill stood at $6.7 million in 2021, then dropped by 0.17% to $6.7 million in 2022, then changed by 0.0% to $6.7 million in 2023, then changed by 0.0% to $6.7 million in 2024.
- The last three reported values for Goodwill were $6.7 million (Q3 2024), $6.7 million (Q2 2024), and $6.7 million (Q1 2024) per Business Quant data.